NanoViricides Story

<div class='circular--portrait' style='background:#9CBEFD;color: #ffffff;font-size:4em;'>NI</div>
NNVC -- USA Stock  

USD 3.85  0.11  2.78%

It appears NanoViricides Inc may not have a good chance to recover from the current slip as its shares fell again. This firm's current daily volatility is 6.14 percent, with a beta of -1.51 and an alpha of -0.6 over DOW. As some investors are moving away from the current market volatility rise, we are going to go over NanoViricides Inc NEW based on how it reacts to economic swings. I will address the reasons why this entity does not get much respect from investors under the current market uncertainty.
Published over a month ago
View all stories for NanoViricides Inc | View All Stories
Should you pick up NanoViricides after the current volatility slip?
NanoViricides Inc NEW currently holds roughly 6.11 M in cash with (6.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.67. The company secures a Beta (Market Risk) of -1.5071, which conveys a somewhat significant risk relative to the market. Let's try to break down what NanoViricides's beta means in this case. As returns on the market increase, returns on owning NanoViricides Inc are expected to decrease by larger amounts. On the other hand, during market turmoil, NanoViricides Inc is expected to outperform it. Even though it is essential to pay attention to NanoViricides NEW price patterns, it is always good to be careful when utilizing equity historical price patterns. Our philosophy towards estimating any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. NanoViricides Inc exposes twenty-eight different technical indicators, which can help you to evaluate its performance. NanoViricides NEW has an expected return of -0.51%. Please be advised to verify NanoViricides Inc NEW downside variance, and the relationship between the treynor ratio and kurtosis to decide if NanoViricides NEW stock performance from the past will be repeated at some point in the near future.
Investing in NanoViricides Inc, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding NanoViricides Inc along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.

How important is NanoViricides Inc's Liquidity

NanoViricides Inc financial leverage refers to using borrowed capital as a funding source to finance NanoViricides Inc NEW ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. NanoViricides Inc financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between NanoViricides Inc's total debt and its cash.

How NanoViricides utilizes its cash?

To perform a cash flow analysis of NanoViricides Inc, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash NanoViricides Inc is receiving and how much cash it distributes out in a given period. The NanoViricides Inc cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. NanoViricides Inc Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (6.12 Million)

NanoViricides Inc Correlation with Peers

Investors in NanoViricides can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in NanoViricides Inc NEW. Diversification will allow for the same portfolio return with reduced risk. The correlation table of NanoViricides Inc and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities NanoViricides is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage. Please check volatility of NanoViricides for more details

Sale by Theracour Pharma Inc of 10000 shares of NanoViricides Inc

Legal trades by NanoViricides Inc insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
NanoViricides Inc NEW insider trading alert for sale of common stock by Theracour Pharma Inc, the corporate stakeholder, on 17th of April 2020. This event was filed by Nanoviricides Inc with SEC on 2009-07-17. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Another angle On NanoViricides Inc

NanoViricides NEW has Sharpe Ratio of -0.0825, which conveys that the firm had -0.0825% of return per unit of risk over the last month. Macroaxis standpoint towards estimating the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. NanoViricides Inc exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify NanoViricides Inc NEW risk adjusted performance of (0.19), and Mean Deviation of 4.22 to check out the risk estimate we provide.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

NanoViricides Inc has 99 percent chance to stay above $4.95 in 2 months

Current kurtosis is at 5.51. NanoViricides Inc NEW is displaying above-average volatility over the selected time horizon. Investors should scrutinize NanoViricides Inc NEW independently to ensure intended market timing strategies are aligned with expectations about NanoViricides Inc volatility.

The Bottom Line

Whereas some other firms in the biotechnology industry are either recovering or due for a correction, NanoViricides may not be as strong as the others in terms of longer-term growth potentials. To conclude, as of the 22nd of August 2020, our primary 30 days 'Buy-vs-Sell' recommendation on the company is Strong Sell. However, we believe NanoViricides Inc is currently undervalued with very small odds of distress for the next two years.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of NanoViricides Inc NEW. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com